These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36408131)

  • 21. A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas.
    Zhang Z; Zhu H; Wang X; Lin S; Ruan C; Wang Q
    Comput Biol Med; 2023 Mar; 154():106597. PubMed ID: 36708655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes.
    Xiong Z; Zhang L; Fan W
    J Immunol Res; 2022; 2022():6084589. PubMed ID: 35935579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma.
    Li F; Song QZ; Zhang YF; Wang XR; Cao LM; Li N; Zhao LX; Zhang SX; Zhuang XF
    Front Genet; 2022; 13():1008416. PubMed ID: 36186418
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.
    Tang X; Qi C; Zhou H; Liu Y
    Heliyon; 2022 Aug; 8(8):e10164. PubMed ID: 36016532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
    Yang X; Wang G; Gu R; Xu X; Zhu G
    PeerJ; 2020; 8():e10418. PubMed ID: 33304656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma.
    Huang Y; Xiao L; Daba MY; Xu D; Wang Y; Li L; Li Q; Liu B; Qin W; Zhang H; Yuan X
    Clin Epigenetics; 2023 Apr; 15(1):72. PubMed ID: 37120564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
    Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Li J; Sun C
    Pharmgenomics Pers Med; 2021; 14():15-26. PubMed ID: 33447073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
    Ma C; Li F; Luo H
    Ann Transl Med; 2021 Jul; 9(13):1058. PubMed ID: 34422970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
    Zhang A; Yang J; Ma C; Li F; Luo H
    Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 40. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
    Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
    Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.